Clinical Trial Update: A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

View source ↗

Summary

This clinical trial update describes a study following males with hemophilia B who are on prophylaxis with Refixia or REBINYN, with enrollment ongoing by invita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Rebinyn (nonacog beta pegol)
• Refixia (Nonacog Beta Pegol (N9-GP))

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia B | Status: ENROLLING_BY_INVITATION